Skip to main content
Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.
Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.
Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity.
Postnatal estradiol up-regulates lung nitric oxide synthases and improves lung function in bronchopulmonary dysplasia.
Treatment outcomes of patients with HIV and tuberculosis.
Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation.
Effect of ductus ligation on cardiopulmonary function in premature baboons.
Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality.
Surfactant protein profile of pulmonary surfactant in premature infants.
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?